Our Pricing

What Is Mounjaro and How Can Melrose Residents Access It?

Published: 4 October 2026

Mounjaro Melrose residents can now access tirzepatide weight loss injections through UK-registered online pharmacies like Cured Pharmacy, with prices starting from £124.99 and discreet home delivery available across Scotland. As a prescription-only medicine licensed by the MHRA for weight management, Mounjaro requires clinical assessment by a UK prescriber before supply. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription to ensure safe, compliant access to this evidence-based treatment.

How Mounjaro Melrose Patients Can Start Treatment Online

Accessing Mounjaro Melrose services through Cured Pharmacy begins with a free online consultation that takes under three minutes to complete. Our UK-registered clinical team reviews your medical history, current medications, and weight management goals to determine suitability for tirzepatide therapy. If approved by a prescriber, your Mounjaro prescription is dispensed from our GPhC-registered pharmacy (9012511) and delivered discreetly to your Melrose address within 24-48 hours[1].

The entire process is designed for convenience while maintaining the highest clinical standards. Patients receive ongoing support from our pharmacist-led team, including guidance on injection technique, dose escalation schedules, and managing potential side effects. All consultations are conducted by GMC-registered doctors who specialise in weight management and metabolic health, ensuring evidence-based prescribing decisions tailored to individual patient needs.

Mounjaro Melrose Pricing and Transparent Cost Breakdown

Cured Pharmacy offers Mounjaro Melrose patients transparent upfront pricing with no hidden fees. Our tirzepatide injections start from £124.99, with the exact cost depending on your prescribed dose strength (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, or 15mg). New patients can Save £20 off their first order using code Weightlossnew, reducing the initial cost to £124.99[2].

Unlike many UK pharmacies that only reveal prices after lengthy consultations, we display all treatment costs before you begin the assessment. This commitment to pricing transparency reflects our broader mission to make evidence-based weight management accessible across Scotland. Every price includes the medication, clinical consultation, prescription fee, and tracked delivery to your Melrose address.

Dose-Dependent Pricing for Mounjaro Melrose Prescriptions

Mounjaro follows a structured dose escalation protocol, with most patients starting at 2.5mg weekly and gradually increasing to maintenance doses of 10mg or 15mg. The price varies by strength, reflecting the quantity of active tirzepatide per pen. Our pharmacist team provides clear guidance on when to increase your dose based on tolerability and weight loss response, ensuring cost-effective treatment progression.

Clinical Evidence Supporting Mounjaro Melrose Treatment Outcomes

The efficacy of Mounjaro for weight management is supported by the landmark SURMOUNT-1 trial, where participants achieved an average weight reduction of 20.9% with the 15mg dose over 72 weeks[3]. Mounjaro Melrose patients prescribed tirzepatide can expect similar outcomes when combined with lifestyle modifications including reduced-calorie nutrition and increased physical activity.

Tirzepatide works through dual GIP and GLP-1 receptor agonism, a mechanism that distinguishes it from single-agonist treatments like semaglutide. This dual action enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways[4]. Clinical trials demonstrated that up to 91% of participants achieved at least 5% weight loss, with 55% achieving 20% or greater reduction at the highest maintenance dose.

How Mounjaro Melrose Patients Experience Treatment Effects

Most patients notice appetite reduction within the first week of starting Mounjaro, though significant weight loss typically becomes apparent after 4-8 weeks of consistent use. The gradual dose escalation schedule minimises gastrointestinal side effects while allowing your body to adapt to tirzepatide's metabolic effects. Melrose residents report improved satiety, reduced food cravings, and sustainable weight loss when adhering to the prescribed regimen alongside dietary changes.

Mounjaro Melrose Delivery and Discreet Packaging Standards

All Mounjaro Melrose orders are dispatched in 100% discreet packaging with no external indication of pharmaceutical contents. We use temperature-controlled courier services to maintain the 2-8°C cold chain required for tirzepatide stability, ensuring your medication arrives in optimal condition. Tracked delivery allows you to monitor your shipment from our pharmacy to your Melrose address in real-time.

Upon arrival, store your Mounjaro pens in the refrigerator immediately and never freeze them. Each KwikPen contains four weekly doses and should be kept refrigerated until use. Our pharmacist team provides detailed storage instructions and answers any questions about handling your medication safely. If you have concerns about delivery timing or storage, contact our team on (+44) 116 4646009 before placing your order.

Who Can Access Mounjaro Melrose Prescriptions Safely

Mounjaro Melrose prescriptions are available to adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidaemia. Our UK prescribers assess each patient individually, considering medical history, current medications, and contraindications before approving tirzepatide therapy[5].

Certain medical conditions preclude Mounjaro use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy. Pregnant or breastfeeding individuals cannot use tirzepatide due to insufficient safety data. Our clinical team conducts thorough screening to ensure Mounjaro is appropriate and safe for your specific health profile.

Mounjaro Melrose Contraindications and Safety Screening

During your online consultation, you'll be asked detailed questions about thyroid disorders, pancreatitis history, kidney function, and concurrent medications. This screening process protects patient safety by identifying potential drug interactions or conditions that may increase adverse event risk. If tirzepatide is not suitable for you, our prescribers can recommend alternative weight management options available through Cured Pharmacy, including semaglutide or orlistat-based treatments.

Managing Side Effects of Mounjaro Melrose Treatment

The most common side effects reported by Mounjaro Melrose patients include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, particularly during the initial weeks of treatment and following dose increases[6]. These gastrointestinal symptoms are typically mild to moderate and diminish as your body adapts to tirzepatide. Eating smaller, more frequent meals and avoiding high-fat foods can help minimise digestive upset.

Serious adverse events are rare but require immediate medical attention. Contact your GP or NHS 111 if you experience severe abdominal pain that radiates to your back (potential pancreatitis), visual changes, persistent vomiting leading to dehydration, or signs of allergic reaction. Our pharmacist team provides comprehensive side effect guidance with every Mounjaro Melrose prescription and remains available to answer questions throughout your treatment journey. Never discontinue tirzepatide abruptly without consulting a healthcare professional.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Public Assessment Report: Mounjaro 2.5 mg solution for injection in pre-filled pen. MHRA. [accessed 4 October 2026]
2. National Institute for Health and Care Excellence. (2023). Tirzepatide for managing overweight and obesity [TA1058]. NICE. [accessed 4 October 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 4 October 2026]
4. Frias, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 4 October 2026]
5. Electronic Medicines Compendium. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. EMC. [accessed 4 October 2026]
6. Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., ... & SURMOUNT-1 Investigators. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity. JAMA, 325(14), 1403-1413. [accessed 4 October 2026]
7. Wilding, J. P., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., ... & STEP 1 Study Group. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide. Diabetes, Obesity and Metabolism, 24(8), 1553-1564. [accessed 4 October 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 4 October 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 4 October 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 4 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.